Variable | POAF (n = 37) | No POAF (n = 91) | P value |
---|---|---|---|
Age (years) | 65.7 ± 6.4 | 59.1 ± 7.6 | 0.002 |
Gender | Â | Â | Â |
 Male | 29 (78.4 %) | 77 (84.6 %) | 0.397 |
 Female | 8 (21.6 %) | 14 (15.4 %) | |
Diabetes | 12 (32.4Â %) | 29 (31.9Â %) | 0.951 |
Hypertension | 24 (64.9Â %) | 55 (60.4Â %) | 0.641 |
Hypercholesterolemia | 25 (67.6Â %) | 59 (64.8Â %) | 0.768 |
Previous myocardial infarction | 15 (40.5Â %) | 37 (40.7Â %) | 0.99 |
Previous cerebral attack | 3 (30Â %) | 7 (70Â %) | 0.937 |
Peripheral vascular disease | 0 (0Â %) | 1 (1.1Â %) | 0.522 |
Chronic renal insufficiency | 1 (2.7Â %) | 9 (9.9Â %) | 0.17 |
NYHA score | Â | Â | Â |
 I | 3 (8.1 %) | 8 (8.8 %) | 0.994 |
 II | 25 (67.6 %) | 61 (67.0 %) | |
 III | 7 (18.9 %) | 18 (19.8 %) | |
 IV | 2 (5.4 %) | 4 (4.4 %) | |
Diseased vessels | Â | Â | Â |
 1 | 1 (2.7 %) | 2 (2.2 %) | 0.967 |
 2 | 4 (10.8 %) | 9 (9.8 %) | |
 3 | 32 (86.5 %) | 80 (88.0 %) | |
LVEF ≤ 50 % | 6 (16.2 %) | 13 (14.3 %) | 0.781 |
Preoperative medications | Â | Â | Â |
 Beta-blockers | 30 (81.1 %) | 78 (85.7 %) | 0.513 |
 ACEI/ARB | 18 (48.6 %) | 41 (45.1 %) | 0.712 |
 Ca2 + −channel blocker | 19 (51.4 %) | 51 (56.0 %) | 0.629 |
Mean CPB time (min) | 107.2 ± 35.4 | 79.1 ± 31.9 | 0.023 |
Mean aortic clamp time (min) | 74.9 ± 25.1 | 48.6 ± 24.4 | 0.017 |
Mean intensive care unit stay (days) | 5.2 ± 3.6 | 4.9 ± 2.7 | 0.81 |